Knollwood Investment Advisory LLC Acquires New Holdings in Omada Health, Inc. $OMDA

Knollwood Investment Advisory LLC acquired a new stake in Omada Health, Inc. (NASDAQ:OMDAFree Report) in the fourth quarter, according to the company in its most recent filing with the SEC. The firm acquired 210,763 shares of the company’s stock, valued at approximately $3,326,000. Knollwood Investment Advisory LLC owned about 0.36% of Omada Health at the end of the most recent reporting period.

Other large investors have also added to or reduced their stakes in the company. Quarry LP bought a new position in Omada Health in the 4th quarter valued at approximately $29,000. TD Waterhouse Canada Inc. bought a new position in Omada Health in the 4th quarter valued at approximately $32,000. Raymond James Financial Inc. bought a new position in Omada Health in the 2nd quarter valued at approximately $32,000. Inlight Wealth Management LLC acquired a new position in shares of Omada Health during the fourth quarter worth $45,000. Finally, Strs Ohio lifted its holdings in shares of Omada Health by 151.0% during the fourth quarter. Strs Ohio now owns 4,267 shares of the company’s stock worth $67,000 after purchasing an additional 2,567 shares during the period.

Omada Health Stock Performance

Omada Health stock opened at $17.14 on Friday. Omada Health, Inc. has a 52-week low of $10.28 and a 52-week high of $26.92. The firm has a 50 day moving average price of $15.35 and a two-hundred day moving average price of $14.83. The firm has a market cap of $1.02 billion and a price-to-earnings ratio of -63.48.

Omada Health (NASDAQ:OMDAGet Free Report) last released its quarterly earnings results on Thursday, May 7th. The company reported ($0.05) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.08) by $0.03. Omada Health had a negative net margin of 2.22% and a negative return on equity of 1.82%. The firm had revenue of $78.05 million during the quarter. As a group, equities research analysts predict that Omada Health, Inc. will post -0.01 EPS for the current fiscal year.

Insider Transactions at Omada Health

In other Omada Health news, President Wei-Li Shao sold 2,829 shares of the firm’s stock in a transaction that occurred on Wednesday, April 8th. The shares were sold at an average price of $12.71, for a total transaction of $35,956.59. Following the completion of the transaction, the president owned 328,850 shares in the company, valued at approximately $4,179,683.50. This trade represents a 0.85% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders own 6.38% of the company’s stock.

Wall Street Analysts Forecast Growth

Several brokerages recently weighed in on OMDA. Morgan Stanley reduced their price objective on shares of Omada Health from $32.00 to $30.00 and set an “overweight” rating on the stock in a research note on Friday, March 6th. Citizens Jmp boosted their price objective on shares of Omada Health from $18.00 to $21.00 and gave the stock a “market outperform” rating in a research note on Friday, May 8th. The Goldman Sachs Group reissued a “buy” rating on shares of Omada Health in a research note on Friday, May 8th. Needham & Company LLC reissued a “buy” rating and issued a $28.00 price objective on shares of Omada Health in a research note on Friday, May 8th. Finally, Weiss Ratings reissued a “sell (e+)” rating on shares of Omada Health in a research note on Thursday, June 4th. Ten analysts have rated the stock with a Buy rating, two have issued a Hold rating and one has given a Sell rating to the company. According to MarketBeat, the company has a consensus rating of “Moderate Buy” and an average price target of $22.91.

Get Our Latest Stock Analysis on Omada Health

Omada Health Company Profile

(Free Report)

Omada Health is a digital health company that specializes in the prevention and management of chronic conditions through personalized, technology-driven programs. The company’s platform combines data analytics, behavioral science and human coaching to support individuals at risk for or living with conditions such as prediabetes, type 2 diabetes, hypertension and musculoskeletal disorders. Participants access the program via a mobile app or web portal, where they receive tailored curriculum, feedback on health metrics and ongoing virtual coaching.

In addition to its core disease-management offerings, Omada Health has expanded its services to include mental health support and digital therapeutics for weight management.

Featured Stories

Want to see what other hedge funds are holding OMDA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Omada Health, Inc. (NASDAQ:OMDAFree Report).

Institutional Ownership by Quarter for Omada Health (NASDAQ:OMDA)

Receive News & Ratings for Omada Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Omada Health and related companies with MarketBeat.com's FREE daily email newsletter.